NBP Stock Summary and Trading Ideas (Novabridge Biosciences - American Depositary Shares | NASDAQ:NBP)

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

What symbol and exchange does Novabridge Biosciences - American Depositary Shares shares trade?

Novabridge Biosciences - American Depositary Shares trades on the NASDAQ stock market under the symbol NBP.

What is Novabridge Biosciences - American Depositary Shares stock price doing today?

As of June 18, 2026, NBP stock price declined to $1.50 with 637,755 million shares trading.

What is Novabridge Biosciences - American Depositary Shares's Beta?

NBP has a beta of 1.01, meaning it tends to be more sensitive to market movements. NBP has a correlation of 0.04 to the broad based SPY ETF.

How much is Novabridge Biosciences - American Depositary Shares worth?

NBP has a market cap of $172.90 million. This is considered a Micro Cap stock.

What are the top ETFs holding Novabridge Biosciences - American Depositary Shares?

The top ETF exchange traded funds that NBP belongs to (by Net Assets): IBB, SPEM, EWX, QQQS, GXC.

What are the support and resistance levels for Novabridge Biosciences - American Depositary Shares (NBP)?

NBP support price is $1.49 and resistance is $1.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NBP shares will trade within this expected range on the day.